Antazoline/naphazoline ophthalmic Interactions
There are 49 drugs known to interact with antazoline/naphazoline ophthalmic, along with 4 disease interactions. Of the total drug interactions, 6 are major, and 43 are moderate.
- View all 49 medications that may interact with antazoline/naphazoline ophthalmic
- View antazoline/naphazoline ophthalmic disease interactions (4)
Most frequently checked interactions
View interaction reports for antazoline / naphazoline ophthalmic and the medicines listed below.
- Acetylsalicylic Acid (aspirin)
- Acetylsalicylic Acid (aspirin)
- Activated Charcoal (charcoal)
- Activated Charcoal (charcoal)
- Advair Diskus (fluticasone / salmeterol)
- Advair Diskus (fluticasone / salmeterol)
- Alcaine (proparacaine ophthalmic)
- Alcaine (proparacaine ophthalmic)
- Alocril (nedocromil ophthalmic)
- Alocril (nedocromil ophthalmic)
- Betnovate (betamethasone topical)
- Betnovate (betamethasone topical)
- Biktarvy (bictegravir / emtricitabine / tenofovir alafenamide)
- Biktarvy (bictegravir / emtricitabine / tenofovir alafenamide)
- Iodides (sodium iodide)
- Iodides (sodium iodide)
- L-Carnitine (levocarnitine)
- L-Carnitine (levocarnitine)
- Maxitrol (dexamethasone / neomycin / polymyxin b ophthalmic)
- Maxitrol (dexamethasone / neomycin / polymyxin b ophthalmic)
- Paracetamol (acetaminophen)
- Paracetamol (acetaminophen)
- Vitamin B12 (cyanocobalamin)
- Vitamin B12 (cyanocobalamin)
- Vitamin B6 (pyridoxine)
- Vitamin B6 (pyridoxine)
- Xalatan (latanoprost ophthalmic)
- Xalatan (latanoprost ophthalmic)
- Xanax (alprazolam)
- Xanax (alprazolam)
Antazoline/naphazoline ophthalmic disease interactions
There are 4 disease interactions with antazoline / naphazoline ophthalmic which include:
Report options
QR code containing a link to this page
More about antazoline / naphazoline ophthalmic
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
See also:
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.